Article transfer service
No need to reformat. No need to resubmit
Our latest improvement to the manuscript submission process is a complimentary Article Transfer Service (ATS) designed to save authors valuable time and effort when submitting to our journals.
What does this mean for me?
If you are unsuccessful in your original manuscript submission, you can decide to have your manuscript transferred to another more suitable journal by our experienced Managing Editor, without the need to reformat. The service is freely available to all submitting authors within the Elsevier Immunology family and aims to save you valuable time and effort.
Benefits:
- No need to reformat or resubmit- we will transfer your manuscript for you
- Publish faster
- Maximize your publication options
- Keep the first submission date of your manuscript
- Remain in control of the submission process with minimal effort
How can I be involved?
Elsevier is helping to improve manuscript submission and peer review processes
Peer review plays an integral role in the interaction and communication between authors, readers, reviewers and editors as the established method to evaluate the quality of science. We recognize, though, that there are shortcomings and sometimes even frustrations associated with the traditional manuscript submission and peer review processes. Our aim is to help facilitate and develop fast, effective and truly innovative solutions to improve the overall manuscript submission and peer review process for all individuals concerned.
Traditional publishing processes are changing and in this context we have established a family cluster of linked journals within the immunology field. This enables us to foster collaboration between those journals, helping us to deliver more options and better services to improve the publication process.
Journals in the Elsevier Immunology family include:
![]() |
Cellular Immunology Editor-in-Chief: N. Sarvetnick Impact Factor: 1.974 5-Year Impact Factor: 2.265 Issues per year: 12 |
![]() |
Clinical Immunology Editor-in-Chief: G. Tsokos The Official Journal of the Federation of Clinical Immunology Societies (FOCIS) Impact Factor: 4.046 5-Year Impact Factor: 3.893 |
![]() |
Cytokine Editors: Sir Gordon W. Duff andS.K. Durum Official journal of the International Cytokine Society Impact Factor: 3.019 5-Year Impact Factor: 3.171 |
![]() |
Developmental and Comparative Immunology Editor-in-Chief: K. Söderhäll Official Journal of the International Society of Developmental and Comparative Immunology Impact Factor: 3.268 5-Year Impact Factor: 3.445 |
![]() |
Fish and Shellfish Immunology Editors: C.J. Secombes and I. Hirono Impact Factor: 3.322 5-Year Impact Factor: 3.715 |
![]() |
Immunology Letters Editor-in-Chief: Vito Pistoia Official Journal of the European Federation of Immunological Societies (EFIS), a member of the International Union of Immunological Societies Impact Factor: 2.526 5-Year Impact Factor: 2.698 |
![]() |
International Immunopharmacology Editor-in-Chief: J.E. Talmadge Impact Factor: 2.376 5-Year Impact Factor: 2.561 |
![]() |
Journal of Autoimmunity Co Editors-in-Chief M.E. Gershwin Y. Shoenfeld Impact Factor: 7.368 5-Year Impact Factor: 5.165 |
![]() |
Journal of Immunological Methods Editors: M.C. Nussenzweig Official Journal of the Association of Medical Laboratory Immunologists Impact Factor: 2.203 5-Year Impact Factor: 2.285 Issues per year: 24 |
![]() |
Molecular Immunology Editor -in-Chief: J. Villadangos Impact Factor: 2.897 5-Year Impact Factor: 3.023 |
![]() |
Our online only, author pays open access journal covering all aspects of immunology
Managing Editor: Angela Schena |
![]() |
Transplant Immunology Editor -in-Chief: Frans Claas Impact Factor: 1.459 5-Year Impact Factor: 1.649 |
![]() |
Veterinary Immunology and Immunopathology Editor -in-Chief: C.L. Baldwin, C.J. Howard, J. Naessens Impact Factor: 2.076 5-Year Impact Factor: 2.194 Issues per year: 24 |
Need more information?
Please contact our Elsevier Managing Editor at immats@elsevier.com













